Page last updated: 2024-09-05

regadenoson and Reperfusion Injury

regadenoson has been researched along with Reperfusion Injury in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Beller, JP; Boys, JA; Charles, EJ; Conaway, MR; Cosner, M; Kron, IL; Krupnick, AS; Lau, CL; Linden, J; Mannem, HC; Mehaffey, JH; Petroni, G; Phillips, J; Zhao, Y	1

Trials

1 trial(s) available for regadenoson and Reperfusion Injury

Article	Year
Adenosine A2A receptor agonist (regadenoson) in human lung transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2020, Volume: 39, Issue:6 Topics: Adenosine A2 Receptor Agonists; Female; Follow-Up Studies; Humans; Lung Transplantation; Male; Middle Aged; Purines; Pyrazoles; Reperfusion Injury; Retrospective Studies; Treatment Outcome	2020

Article

Year

Adenosine A2A receptor agonist (regadenoson) in human lung transplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2020, Volume: 39, Issue:6

Topics: Adenosine A2 Receptor Agonists; Female; Follow-Up Studies; Humans; Lung Transplantation; Male; Middle Aged; Purines; Pyrazoles; Reperfusion Injury; Retrospective Studies; Treatment Outcome

2020